Demystifying Wound Care Excellence: Unlocking the Secrets to Transformational Healing

Randall Spencer, Vice President of Clinical Innovations Mr. Spencer is the co-founder of Surgical Biologics, a leading processor of amnion tissue for use in a variety of surgical implants. Since the founding of Surgical Biologics in 2006, he led the development of the proprietary PURION® process, which processes human amniotic membrane to produce a safe, effective and minimally manipulated implant for homologous use. He has been a pioneer in the development of the latest advances in processing amniotic membrane tissue. MIMEDX® acquired Surgical Biologics in January 2011, and Mr. Spencer currently serves as Vice President of Clinical Innovation

Kathleen has recently celebrated her 54th year of working in the medical reimbursement arena. As the founder and president of her own consulting company, Kathleen D. Schaum & Associates, Inc. she shares her 50+ years of knowledge and experience with wound/ulcer management stakeholders.

Dr. John Harper joined MIMEDX as Chief Science Officer and Senior Vice President of Research and Product Development in June 2021. Dr. Harper has over 40 peer-reviewed publications and his principal areas of research interest are extracellular matrix biochemistry, tissue regeneration, and wound healing. He received his Ph.D. in Biomedical Sciences from The University of Texas, M.D. Anderson Cancer Center in Houston and completed post-doctoral fellowships in cancer biochemistry and cell biology at Scripps Clinic in La Jolla, California and the National Cancer Institute in Bethesda, Maryland.

Dr. Harper serves on the Board of Directors of Kent Imaging, Nanomedic Technologies, and the American College of Wound Healing and Tissue Repair.

Dr. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. Dr. Armstrong holds a Master of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He is founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA).

Dr. Armstrong has produced more than 740 peer-reviewed research papers in dozens of scholarly medical journals as well as over 120 books or book chapters. He is founding co- Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now in its fourth edition.

Armstrong is Director of USC’s National Science Foundation (NSF) funded Center to Stream Healthcare in Place (C2SHiP) which places him at the nexus of the merger of consumer electronics, wearables, and medical devices in an effort to maximize hospital-free and activity-rich days.

Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards and degrees by universities and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25^th and youngest-ever member elected to the Podiatric Medicine Hall of Fame. He was the first surgeon to be appointed University Distinguished Outreach Professor at the University of Arizona. He was also the first podiatric surgeon to be selected as President of Faculty at Keck School of Medicine of USC. Furthermore, he was the first podiatric surgeon to become a member of the Society of Vascular Surgery, and the first US podiatric surgeon named fellow of the Royal College of Surgeons, Glasgow. He is the 2010 and youngest ever recipient of both the ADA’s Roger Pecoraro Award and 2023 recipient of the ISDF’s Karel Bakker Award, the highest awards given in the field.

Dr. Armstrong is past Chair of Scientific Sessions for the ADA’s Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association. He sits on the Infectious Disease Society of America’s (IDSA) Diabetic Foot Infection Advisory Committee and is the US appointed delegate to the International Working Group on the Diabetic Foot (IWGDF). Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world. He is also the Founding President of the American Limb Preservation Society (ALPS), a medical and surgical society dedicated to building interdisciplinary teams to eliminate preventable amputation in the USA and worldwide.

Matthew Murphy, MD, PhD, FRCSC is a board certified, fellowship trained plastic and reconstructive surgeon at Stanford University in Palo Alto, California.

Dr. Murphy has a scientific background, receiving his PhD in Medical Biophysics from Western University in Canada. He then completed his medical training at the University of Ottawa, followed by Plastic and Reconstructive Surgical residency at the University of Toronto, Canada. Dr. Murphy further specialized by completing a fellowship in Hand and Microsurgery at the University of Toronto. After completion of subspecialty fellowship training, he accepted a position at Stanford University in the Division of Plastic Surgery, where continues to work as Clinical Assistant Professor for the last 7 years. Additionally, he has great interest in the education of trainees and is completing his 5^th year as the Associate Program Director in the Division of Plastic surgery. There, he helps oversee the educational component of the residency training program.

Clinically, Dr. Murphy specializes in reconstructive microsurgery and complex wounds. His faculty position, as one of the University’s microsurgeons, focuses on limb salvage after trauma and cancer extirpation.Dr. Murphy has a very large wound care practice, dedicating over 50% of his full-time clinical practice to these patients. In his career, he has authored peer reviewed manuscripts and book chapters, with recent publications focusing on complex wounds. Dr. Murphy is an active member a multidisciplinary group focused on limb preservation at Stanford.

Dr. Trent Brookshier, DPM, is an experienced podiatrist serving patients at North Park Podiatry in San Diego, California. 

Dr. Brookshier grew up in El Cajon, California, and attended Christian High School, where he met his high school sweetheart, Annalisa. After graduating, he completed his bachelor's degree at The University of California, Irvine (ZOT! ZOT!), living in the honors dorms (called the Shire of Middle Earth for fellow “Lord of the Rings” fans). 

Upon graduation, Dr. Brookshier worked at the University of California San Diego Hospital as a lab technician on the organ procurement team. He then attended the Western University of Health Sciences in Pomona, California, and completed his three-year surgical residency at Scripps Mercy Hospital in San Diego. He completed further trauma and reconstructive training at Kaiser Permanente Fontana Medical Center in Fontana, California. 

Dr. Brookshier completed externships nationwide at several hospitals, such as Harvard's teaching facility in Cambridge, Massachusetts, Swedish Seattle in Washington, and Cedars-Sinai Medical Center in Los Angeles, California. During his residency, Dr. Brookshier completed over 1,500 surgical procedures.

Dr. Brookshier is passionate about progressing the field of podiatric medicine and helping to improve diabetic care. He has presented novel studies nationwide and most recently spoke in Hong Kong and South Korea, sharing his results at the International Diabetes Federation.

Dr. Brookshier and his wife have been married for ten years and have three sons: Bryer, Desmond, and Calvin. Outside work, he enjoys playing sports, hiking, dancing, running, beach days, and watching “Survivor.”